Substance Use, Pregnancy, and HIV/AIDS: Treatment Programs for Pregnant Women
This living document identifies existing substance use treatment programs and services available to pregnant women and pregnant women living with HIV/AIDS in North America, with a particular focus on Saskatchewan. The information provided through the current environmental scan is useful both for pregnant women who use substances who are seeking services, and for healthcare professionals, who can use this information to assist women in accessing services that are appropriate to their needs. Ideally, this would be done as part of a multidisciplinary team, where the referring professional continues to be involved in the care of the woman. It is hoped that the information provided will increase awareness of the existing substance use treatment centres and programs for pregnant women, with the goal of potentially increasing referrals to and use of these programs.
HIV and Pregnancy – A Guide to Care
Guide and Manual, Revised 2020
This guide covers such topics as HIV/AIDS in Saskatchewan, Modes of Transmission of HIV, HIV Testing During Pregnancy, Prenatal Algorithm, HIV Treatment and Drug Management, After-Care for Babies of HIV Positive Women, Barriers to HIV Transmission Prevention and Prenatal Care, and Motivational Approaches.SKU: 7-008
Sexually Transmitted Infections: Are You Positive You’re Negative?
This brochure, designed for use with youth, explains what sexually transmitted infections (STIs) are, how to avoid STIs, and how to find out if you have an STI. It also includes information about the effects of STIs on fertility, pregnancies, and newborn babies.SKU: 7-002
The Impact of Substance Use on Mother-to-child Transmission of HIV
This literature review aimed to assess the impact of substance use on mother-to-child transmission (MTCT) of HIV. Such a review was deemed necessary due to Saskatchewan’s unique HIV profile. Specifically, new cases of HIV in Saskatchewan are: (a) the highest in Canada; (b) most often associated with injection drug use (IDU); and (c) increasing rapidly in women of childbearing age (ages 15 to 39). The primary questions addressed in the report include: Why do substance use services need to be focused on to avoid MTCT of HIV? How does having a substance use issue influence high risk behaviours that can lead to HIV infection? How does having a substance use issue affect virus progression and impact the health of pregnant women living with HIV?SKU: 7-508